Flucelvax Quadrivalent
NDC Package 70461-421-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Flucelvax Quadrivalent is a . Marketed by Seqirus Inc., this product is identified by NDC 70461-421 and is authorized under FDA application BLA125408.

Identification & Billing

NDC Package Code
70461-421-10
Package Description
1 VIAL, MULTI-DOSE in 1 CARTON / 5 mL in 1 VIAL, MULTI-DOSE (70461-421-11)
Product Code
70461-421
11-Digit Billing Format
70461042110
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Flucelvax Quadrivalent (multi-dose Vial)
Dosage Form
-

Regulatory & Marketing

Labeler Name
Seqirus Inc.
FDA Application #
BLA125408
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
07-02-2020
End Marketing Date
07-31-2022
Listing Expiration
07-31-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70461-421-10 identifies a specific commercial package of 1 vial, multi-dose in 1 carton / 5 ml in 1 vial, multi-dose (70461-421-11) of Flucelvax Quadrivalent (multi-dose Vial), labeled by Seqirus Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Seqirus Inc. on July 02, 2020. The current certification is valid through July 31, 2022.

How is this Seqirus Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70461042110. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70461-421-10
11-Digit CMS (5-4-2)
70461-0421-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.